At EUROAPI, we’re reinventing active ingredient solutions to meet customers’ and patients’ needs around the world in a sustainable way.
Euroapi offers the largest portfolio of APIs in the world, counting upwards of 200 ingredients, addressing a wide population of patients and providing global coverage for more than 80 countries.
Euroapi is a global leader in small molecule APIs, and our strong innovation and R&D capabilities allow us to accelerate our development in complex molecules segments through CDMO.
You are an investor, an analyst or an individual shareholder and have a question about EUROAPI, please contact the Investor Relations department.
The role of the Investor Relations department is to maintain a transparent and comprehensive dialogue with the financial community about EUROAPI's strategy, outlook and financial data, its economic environment and any other useful information.
Head of Investor Relations
You are a journalist and have a question about Euroapi, please contact the Global Media Relations department.
Laurence Bollack, Head of Global Media Relations
+33 (0)6 81 86 80 19 • email@example.com
Please note the contact details are only for journalists.
Partner with us
This section is currently empty.